Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Starling

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cytometry|January 1, 1990
Selective cloning of hybridoma cells for enhanced immunoglobulin production using flow cytometric cell sorting and automated laser nephelometryP Marder, R S Maciak, R L Fouts, et al.
Cancer Research|December 15, 1988
Tissue distribution and cellular location of the antigens recognized by human monoclonal antibodies 16.88 and 28A32J J Starling, R J Cote, P Marder, et al.
The Prostate|January 1, 1985
Antiprostate carcinoma monoclonal antibody (D83.21) cross reacts with a membrane antigen expressed on cytomegalovirus-transformed human fibroblastsA E Campbell, M L Beckett, J J Starling, et al.
Bioconjugate Chemistry|January 1, 1996
Dextran modification of a Fab'--beta-lactamase conjugate modulated by variable pretreatment of Fab' with amine-blocking reagentsS D Mikolajczyk, D L Meyer, R Fagnani, et al.
Bioconjugate Chemistry|January 1, 1992
Preparation and characterization of a beta-lactamase-Fab' conjugate for the site-specific activation of oncolytic agentsD L Meyer, L N Jungheim, S D Mikolajczyk, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibodyJ J Starling, R S Maciak, N A Hinson, et al.
Cancer Research|August 1, 1982
Monoclonal antibodies to human prostate and bladder tumor-associated antigensJ J Starling, S M Sieg, M L Beckett, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 1, 1979
A statistical evaluation of the binding of ferritin-conjugated lectins to the surface of rat cells. Topographical variations as a function of lectin concentration and cell typeD C Hixson, M F Miller, K Maruyama, et al.
Bioconjugate Chemistry|November 1, 1994
High yield, site-specific coupling of N-terminally modified beta-lactamase to a proteolytically derived single-sulfhydryl murine Fab'S D Mikolajczyk, D L Meyer, J J Starling, et al.
Cancer Research|November 1, 1988
Development of a dual label fluorescence technique that can be utilized to elucidate the mechanism of action of monoclonal antibody-drug conjugatesJ J Starling, N A Hinson, P Marder, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cytometry|January 1, 1990
Selective cloning of hybridoma cells for enhanced immunoglobulin production using flow cytometric cell sorting and automated laser nephelometryP Marder, R S Maciak, R L Fouts, et al.
Cancer Research|December 15, 1988
Tissue distribution and cellular location of the antigens recognized by human monoclonal antibodies 16.88 and 28A32J J Starling, R J Cote, P Marder, et al.
The Prostate|January 1, 1985
Antiprostate carcinoma monoclonal antibody (D83.21) cross reacts with a membrane antigen expressed on cytomegalovirus-transformed human fibroblastsA E Campbell, M L Beckett, J J Starling, et al.
Bioconjugate Chemistry|January 1, 1996
Dextran modification of a Fab'--beta-lactamase conjugate modulated by variable pretreatment of Fab' with amine-blocking reagentsS D Mikolajczyk, D L Meyer, R Fagnani, et al.
Bioconjugate Chemistry|January 1, 1992
Preparation and characterization of a beta-lactamase-Fab' conjugate for the site-specific activation of oncolytic agentsD L Meyer, L N Jungheim, S D Mikolajczyk, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibodyJ J Starling, R S Maciak, N A Hinson, et al.
Cancer Research|August 1, 1982
Monoclonal antibodies to human prostate and bladder tumor-associated antigensJ J Starling, S M Sieg, M L Beckett, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 1, 1979
A statistical evaluation of the binding of ferritin-conjugated lectins to the surface of rat cells. Topographical variations as a function of lectin concentration and cell typeD C Hixson, M F Miller, K Maruyama, et al.
Bioconjugate Chemistry|November 1, 1994
High yield, site-specific coupling of N-terminally modified beta-lactamase to a proteolytically derived single-sulfhydryl murine Fab'S D Mikolajczyk, D L Meyer, J J Starling, et al.
Cancer Research|November 1, 1988
Development of a dual label fluorescence technique that can be utilized to elucidate the mechanism of action of monoclonal antibody-drug conjugatesJ J Starling, N A Hinson, P Marder, et al.
Pageof 4